UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.256

2024

Volltextzugriff (PDF)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists

Pharmaceuticals (Basel, Switzerland), 2023-04, Vol.16 (5), p.674

2023

Volltextzugriff (PDF)

Exendin‐4 analogs in insulinoma theranostics

Journal of labelled compounds & radiopharmaceuticals, 2019-08, Vol.62 (10), p.656-672

2019

Volltextzugriff (PDF)

Repeated Application and Removal of Polyisocyanopeptide Hydrogel Wound Dressings in a Splinted Full-Thickness Wound Model

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5127

2023

Volltextzugriff (PDF)

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R

Pharmaceutics, 2023-02, Vol.15 (3), p.796

2023

Volltextzugriff (PDF)

Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa

Molecules (Basel, Switzerland), 2018-08, Vol.23 (9), p.2100

2018

Volltextzugriff (PDF)

Noninvasive Monitoring of Glycemia-Induced Regulation of GLP-1R Expression in Murine and Human Islets of Langerhans

Diabetes (New York, N.Y.), 2020-11, Vol.69 (11), p.2246-2252

2020

Volltextzugriff (PDF)

Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3

Scientific reports, 2017-08, Vol.7 (1), p.1-6, Article 7232

2017

Volltextzugriff (PDF)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan

Scientific reports, 2017-05, Vol.7 (1), p.1751-9, Article 1751

2017

Volltextzugriff (PDF)

Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors

Molecular imaging, 2011-03, Vol.10

2011

Volltextzugriff (PDF)

(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell mass

Diabetes (New York, N.Y.), 2015-04, Vol.64 (4), p.1324-1328

2015

Volltextzugriff (PDF)

Tungstate versus Molybdate Adsorption on Oxidic Surfaces: A Chemical Approach

The journal of physical chemistry. B, 2000-09, Vol.104 (35), p.8456-8461

2000

Volltextzugriff (PDF)

Spacer Effects on in vivo Properties of DOTA-Conjugated Dimeric [Tyr3]Octreotate Peptides Synthesized by a "CuI-Click" and "Sulfo-Click" Ligation Method

Chembiochem : a European journal of chemical biology, 2011-03, Vol.12 (5), p.750-760

2011

Volltextzugriff (PDF)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention

Molecular pharmaceutics, 2023-07, Vol.20 (7), p.3519-3528

2023

Volltextzugriff (PDF)

Validation of 111 In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Diabetes (New York, N.Y.), 2018-10, Vol.67 (10), p.2012

2018

Volltextzugriff (PDF)

Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis

Molecular pharmaceutics, 2019-09, Vol.16 (9), p.4024-4030

2019

Volltextzugriff (PDF)

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)

European journal of nuclear medicine and molecular imaging, 2023-03, Vol.50 (4), p.996-1004

2023

Volltextzugriff (PDF)

From Mice to Humans: The Exocrine Pancreas Does Not Matter in Human GLP-1 Receptor Imaging

Journal of Nuclear Medicine, 2021-05, Vol.62 (5), p.745-745

2021

Volltextzugriff (PDF)

Validation of ^sup 111^In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Diabetes (New York, N.Y.), 2018-10, Vol.67 (10), p.2012

2018

Volltextzugriff (PDF)

Validation of 111In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Diabetes (New York, N.Y.), 2018-10, Vol.67 (10), p.2012-2018

2018

Volltextzugriff (PDF)

Enhanced Specific Activity by Multichelation of Exendin‑3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging

Molecular pharmaceutics, 2018-02, Vol.15 (2), p.486-494

2018

Volltextzugriff (PDF)

Effect of N -Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177 Lu-Labeled Peptide Analogs Targeting CCK2R

Pharmaceutics, 2023-02, Vol.15 (3)

2023

Volltextzugriff (PDF)

sup 111^In-exendin Uptake in the Pancreas Correlates With the [Beta]-Cell Mass and Not With the [alpha]-Cell Mass

Diabetes (New York, N.Y.), 2015-04, Vol.64 (4), p.1324

2015

Volltextzugriff (PDF)

111In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass

Diabetes (New York, N.Y.), 2015-04, Vol.64 (4), p.1324-1328

2015

Volltextzugriff (PDF)

Effect of IN/I-Terminal Peptide Modifications on In Vitro and In Vivo Properties of [sup.177]Lu-Labeled Peptide Analogs Targeting CCK2R

Pharmaceutics, 2023-02, Vol.15 (3)

2023

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(93)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists

Exendin‐4 analogs in insulinoma theranostics

Repeated Application and Removal of Polyisocyanopeptide Hydrogel Wound Dressings in a Splinted Full-Thickness Wound Model

Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R

Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa

Noninvasive Monitoring of Glycemia-Induced Regulation of GLP-1R Expression in Murine and Human Islets of Langerhans

Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan

Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors

(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell mass

Tungstate versus Molybdate Adsorption on Oxidic Surfaces: A Chemical Approach

Spacer Effects on in vivo Properties of DOTA-Conjugated Dimeric [Tyr3]Octreotate Peptides Synthesized by a "CuI-Click" and "Sulfo-Click" Ligation Method

New Radiolabeled Exendin Analogues Show Reduced Renal Retention

Validation of 111 In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Measuring the Pancreatic β Cell Mass in Vivo with Exendin SPECT during Hyperglycemia and Severe Insulitis

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)

From Mice to Humans: The Exocrine Pancreas Does Not Matter in Human GLP-1 Receptor Imaging

Validation of ^sup 111^In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Validation of 111In-Exendin SPECT for the Determination of the β-Cell Mass in BioBreeding Diabetes-Prone Rats

Enhanced Specific Activity by Multichelation of Exendin‑3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging

Effect of N -Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177 Lu-Labeled Peptide Analogs Targeting CCK2R

sup 111^In-exendin Uptake in the Pancreas Correlates With the [Beta]-Cell Mass and Not With the [alpha]-Cell Mass

111In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass

Effect of IN/I-Terminal Peptide Modifications on In Vitro and In Vivo Properties of [sup.177]Lu-Labeled Peptide Analogs Targeting CCK2R

Suchergebnisse filtern